Chemistry, Pharmaceutical
"Chemistry, Pharmaceutical" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use.
Descriptor ID |
D002626
|
MeSH Number(s) |
H01.158.703.007 H01.181.466
|
Concept/Terms |
Chemistry, Pharmaceutical- Chemistry, Pharmaceutical
- Medicinal Chemistry
- Chemistry, Medicinal
- Pharmaceutic Chemistry
- Pharmaceutical Chemistry
- Chemistry, Pharmaceutic
|
Below are MeSH descriptors whose meaning is more general than "Chemistry, Pharmaceutical".
Below are MeSH descriptors whose meaning is more specific than "Chemistry, Pharmaceutical".
This graph shows the total number of publications written about "Chemistry, Pharmaceutical" by people in this website by year, and whether "Chemistry, Pharmaceutical" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2003 | 0 | 1 | 1 |
2004 | 0 | 1 | 1 |
2005 | 0 | 2 | 2 |
2006 | 1 | 4 | 5 |
2007 | 0 | 1 | 1 |
2008 | 1 | 0 | 1 |
2009 | 0 | 4 | 4 |
2010 | 1 | 0 | 1 |
2011 | 0 | 2 | 2 |
2012 | 1 | 1 | 2 |
2013 | 1 | 1 | 2 |
2014 | 1 | 1 | 2 |
2015 | 2 | 4 | 6 |
2016 | 3 | 2 | 5 |
2017 | 1 | 4 | 5 |
2018 | 1 | 1 | 2 |
2019 | 4 | 2 | 6 |
2020 | 1 | 3 | 4 |
2021 | 1 | 1 | 2 |
2024 | 0 | 5 | 5 |
2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chemistry, Pharmaceutical" by people in Profiles.
-
Elucidating critical factors driving the tabletability flip phenomenon. Int J Pharm. 2025 Mar 15; 672:125337.
-
Direct compression tablet formulation of trimetazidine through systematic screening of oxalate salts. Int J Pharm. 2025 Feb 25; 671:125255.
-
Impact of route of particle engineering on dissolution performance of posaconazole. Int J Pharm. 2025 Jan 25; 669:125025.
-
Advancing the Harmonization of Biopredictive Methodologies through the Product Quality Research Institute (PQRI) Consortium: Biopredictive Dissolution of Dipyridamole Tablets. Mol Pharm. 2024 Oct 07; 21(10):5315-5325.
-
Miscibility of amorphous solid dispersions: A rheological and solid-state NMR spectroscopy study. J Pharm Sci. 2025 Jan; 114(1):119-126.
-
Relative Bioavailability Assessment of Solid Forms by An Artificial Stomach and Duodenum Apparatus. J Pharm Sci. 2024 Aug; 113(8):2506-2512.
-
Delaying the first nucleation event of amorphous solid dispersions above the polymer overlap concentration (c*): PVP and PVPVA in posaconazole. J Pharm Sci. 2025 Jan; 114(1):98-104.
-
Novel Salt-Cocrystals of Berberine Hydrochloride with Aliphatic Dicarboxylic Acids: Odd-Even Alternation in Physicochemical Properties. Mol Pharm. 2021 04 05; 18(4):1758-1767.
-
Direct compression tablet formulation of celecoxib enabled with a pharmaceutical solvate. Int J Pharm. 2021 Mar 01; 596:120239.
-
The impact of solid-state form, water content and surface area of magnesium stearate on lubrication efficiency, tabletability, and dissolution. Pharm Dev Technol. 2021 Feb; 26(2):150-156.